Science Explorer Interactive view Map
Company · Lausanne · Switzerland

Debiopharm (Switzerland)

debiopharm.comROR OpenAlex
World rank, all time
#27,256
of 42,892
Rank in Switzerland
#272
of 429
Research works
126
▲ 16% vs 2013–17
Citations
2.7k
21.3 per fractional work
Top-10% rate
10.9%
record average 16.5%
Open access
40%
world 28%

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.59× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 5.30× its world share, 11 worksBiochemistry, Geneti…Immunology and Microbiology: 1.39× its world share, 1 worksImmunology and Micro…Neuroscience: 1.08× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 6.91× its world share, 1 worksPharmacology, Toxico…Chemical Engineering: 0.79× its world share, 0 worksChemical EngineeringChemistry: 1.83× its world share, 1 worksChemistryComputer Science: 0.24× its world share, 1 worksComputer ScienceEngineering: 0.05× its world share, 0 worksEngineeringEnvironmental Science: 0.17× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.23× its world share, 0 worksMaterials SciencePhysics and Astronomy: 0.19× its world share, 0 worksPhysics and AstronomyHealth Professions: 0.16× its world share, 0 worksHealth ProfessionsMedicine: 2.53× its world share, 20 worksMedicineVeterinary: 9.24× its world share, 0 worksVeterinaryBusiness, Management and Accounting: 0.68× its world share, 1 worksBusiness, Management…Economics, Econometrics and Finance: 0.74× its world share, 1 worksEconomics, Econometr…Social Sciences: 0.12× its world share, 1 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Veterinary, 9.2×. Every wedge is a field page.

Which keywords describe research at Debiopharm (Switzerland)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer Therapy, Chemotherapy, Epidemiology, Medicinal Chemistry, Immune Response, Tumor Microenvironment, Immunotherapy and Cell Death.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 37 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 37 words, with their numbers
  1. Cancer Therapy4▲ 19×14 topics
  2. Epidemiology4▲ 2.5×20 topics
  3. Chemotherapy4▲ 13×11 topics
  4. Inflammation2▲ 2.7×9 topics
  5. Medicinal Chemistry2▲ 20×5 topics
  6. Immune Response2▲ 8.8×5 topics
  7. Immunotherapy2▲ 6.9×7 topics
  8. Cancer2▲ 3.5×10 topics
  9. Tumor Microenvironment2▲ 11×6 topics
  10. Cell Death2▲ 19×4 topics
  11. Monoclonal Antibody2▲ 79×2 topics
  12. Breast Cancer2▲ 16×1 topic
  13. Genome Engineering2▲ 60×1 topic
  14. HER22▲ 136×1 topic
  15. RNA-Guided2▲ 60×1 topic
  16. Targeted Therapy2▲ 18×4 topics
  17. Clinical Trials1▲ 5.3×5 topics
  18. SARS-CoV-21▲ 11×3 topics
  19. Drug Discovery1▲ 14×3 topics
  20. PET Imaging1▲ 19×4 topics
  21. Pandemic1▲ 3.0×3 topics
  22. Antimicrobial Resistance1▲ 15×3 topics
  23. Apoptosis1▲ 10×5 topics
  24. Machine Learning1◆ 0.95×2 topics
  25. Metabolic Regulation1▲ 17×2 topics
  26. Mitochondria1▲ 22×2 topics
  27. Pharmacokinetics1▲ 11×3 topics
  28. Prognostic Factors1▲ 6.6×5 topics
  29. Quality of Life1▲ 2.1×4 topics
  30. Reactive Oxygen Species1▲ 7.1×2 topics
  31. Vaccine1▲ 7.1×3 topics
  32. ACE2 Receptor1▲ 11×2 topics
  33. Healthcare-Associated Infections1▲ 23×2 topics
  34. Neuroprotection1▲ 7.9×4 topics
  35. Tumor Regression1▲ 24×2 topics
  36. Inhibitors1▲ 62×2 topics
  37. Nanoparticles1▲ 2.0×4 topics

Which research topics does Debiopharm (Switzerland) publish most on?

By volume in 2022–2025: CRISPR and Genetic Engineering, HER2/EGFR in Cancer Research, Cancer Treatment and Pharmacology and Computational Drug Discovery Methods.

CRISPR and Genetic Engineering: 2 fractional worksHER2/EGFR in Cancer Research: 2 fractional worksCancer Treatment and Pharmacology: 1 fractional worksComputational Drug Discovery Methods: 1 fractional worksMonoclonal and Polyclonal Antibodies Research: 1 fractional worksPI3K/AKT/mTOR signaling in cancer: 1 fractional worksRadiopharmaceutical Chem…1Radiopharmaceutical Chemistry and Applications: 1 fractional worksChemical Reactions and Isotopes: 1 fractional worksAdenosine and Purinergic Signaling: 1 fractional worksCell death mechanisms an…1Cell death mechanisms and regulation: 1 fractional works
Molecular BiologyOncologyComputational Theory and MathematicsRadiology, Nuclear Medicine and Imaging2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 CRISPR and Genetic Engineering Molecular Biology 2 works
  2. 2 HER2/EGFR in Cancer Research Oncology 2 works
  3. 3 Cancer Treatment and Pharmacology Oncology 1 works
  4. 4 Computational Drug Discovery Methods Computational Theory and Mathematics 1 works
  5. 5 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  6. 6 PI3K/AKT/mTOR signaling in cancer Molecular Biology 1 works
  7. 7 Radiopharmaceutical Chemistry and Applications Radiology, Nuclear Medicine and Imaging 1 works
  8. 8 Chemical Reactions and Isotopes Pharmaceutical Science 1 works
  9. 9 Adenosine and Purinergic Signaling Physiology 1 works
  10. 10 Cell death mechanisms and regulation Molecular Biology 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available40.3%not open59.7%

World: 28% of research is openly available.

with international co-authors61.2%domestic only38.8%

World: 19% is written across borders.

How has Debiopharm (Switzerland)'s research output changed?

Output in 2018–2022 was 16% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Lausanne

All research institutions in Lausanne

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.